Herr Amy E. 4

What Happened
Amy E. Herr, a director of Bio-Techne Corporation (TECH), sold 1,976 shares of company stock in open-market/private sales on February 17, 2026. The reported weighted-average price was $59.10 per share, for total proceeds of approximately $116,791. This was a sale (disposition), which is commonly routine insider selling and does not, by itself, indicate a change in company outlook.

Key Details

• Transaction date: 2026-02-17; filing date (Form 4): 2026-02-19 (appears timely — within the usual 2-business-day window).
• Shares sold: 1,976; weighted-average price: $59.10; aggregate proceeds: $116,791.
• Price range: transactions occurred at prices between $59.091 and $59.1390; the $59.10 figure is a weighted average (Footnote F1).
• Shares owned after the transaction: not specified in the excerpt provided — see the full Form 4 for post-transaction holdings.
• Notable footnotes: filing lists multiple outstanding awards and vesting schedules (RSUs and stock options) for the reporting person, with vesting dates through 2026–2029 (see Footnotes F2–F13). Footnote F8 clarifies each RSU equals one share.
• Transaction code: S = Sale (disposition).

Context

• This filing reports a sale, not a purchase or exercise. Sales by directors can be routine (liquidity, diversification, tax planning) and do not by themselves imply insider pessimism.
• The filing also documents outstanding restricted stock units and options that will vest on various future dates; those are separate from this sale.
• For full details on holdings after the sale and the exact per-trade breakdown within the reported price range, consult the complete Form 4 (the filer offers to provide the number of shares sold at each separate price upon request, per F1).